On Tuesday 23andme organizers in the United Kingdom, 2.31 million pounds (3.1 million dollars) are fined for the private data violations of the company Break the huge data in 2023.
The Information Commissioner Office says that the genetic testing company, which has since submitted a request to protect bankruptcy in Chapter 11 in the United States, has failed to develop “appropriate” security measures to protect the personal information of its users in the United Kingdom, which led to bargaining on these data in the breach. The fine of the United Kingdom comes after a joint investigation by ICO and the Office of the Commissioner for Privacy in Canada.
In a statement, UK Information Commissioner John Edwards described “deep damage”, noting that he revealed sensitive personal information, including family history and health conditions for thousands of people in the UK.
“Security systems were insufficient,” Edwards said. “The warning signs were present, and the company was slow to respond. This was left the most sensitive data for people exposed to exploitation and damage.”
In 2023, Internet criminals violated 23ndme systems using “Dismantling attack attack“The online account bombing with huge groups of user names and stolen passwords in previously unrelated attacks. For months, infiltrators were able to get rid of personal data for more than 6.9 million people, including about 155,000 UK residents.
ICO said on Tuesday that at the time of breach, 23ndme did not require additional verification, such as the biological measurement index or a symbol sent to their phones, to reach user accounts, which violate the UK law. The company has since changed its practices to operate the dual -factor authentication by default.
In addition to the faded demand for its services, the installation costs, in addition to the dull demand for its services A file to protect bankruptcy earlier this year. This step also caused technology and law experts to ask about future security and the privacy of the company’s vast group of genetic samples consumers and personal data.
A offer of Regeneron Pharmaceuticals has been received to buy most of the company’s assets for $ 256 million in cash, but that company was Ultimately last week By TTAM Research Institute, a non -profit institution led by Anne Wogyi, founder of 23andme and former CEO. This deal remains subject to the final approval of the court and the conditions of the usual closure.
https://www.cnet.com/a/img/resize/a65742ddc6bdc0b510b689f7ae377a927d27947b/hub/2025/06/17/4144f2c2-1ee1-40cb-9fd0-da2e11fb6c4d/gettyimages-1167443638.jpg?auto=webp&fit=crop&height=675&width=1200
Source link